GlycoMantra was awarded a SBIR Phase 1 grant to investigate NASH fibrosis.
Related Posts
GlycoMantra will present at the Oncology Investor Conference.
GlycoMantra will present at the Oncology Investor Conference. GlycoMantra has been selected to pitch at the…
GlycoMantra received SBIR Phase 1 grant from the NCI (NIH)
July 18, 2018 GlycoMantra received SBIR Phase 1 grant from the NCI (NIH) GlycoMantra was…